Promoting freedom, innovation, and growth

Connect with IPI

Receive news, research, and updates

Merrill Matthews

Resident Scholar

Merrill Matthews, Ph.D., is a resident scholar with the Institute for Policy Innovation, a research-based, public policy “think tank.”  He is a health policy expert and contributor at Forbes.com. He also serves on the Texas Advisory Committee of the U.S. Commission on Civil Rights.

Dr. Matthews is a past president of the Health Economics Roundtable for the National Association for Business Economics, the largest trade association of business economists. Dr. Matthews also served for 10 years as the medical ethicist for the University of Texas Southwestern Medical Center’s Institutional Review Board for Human Experimentation, and has contributed chapters to several books, including Physician Assisted Suicide: Expanding the Debate and The 21st Century Health Care Leader and, in 2009, Stop Paying the Crooks (on Medicare fraud).  

He has been published in numerous journals and newspapers, including The Wall Street Journal, Investor’s Business Daily, Barron’s, USA Today, Forbes magazine and the Washington Times.  He was an award-winning political analyst for the USA Radio Network. 

Dr. Matthews received his Ph.D. in Humanities from the University of Texas at Dallas

January 11, 2018

Trump Thinks Congress Should Consider the Return of Earmarks


IPI expert referenced: Merrill Matthews

Merrill Matthews at the Institute for Policy Innovation tells KTRH it's not so farfetched; that it might 'grease the skids' for deals to get done.

January 10, 2018

Those Drug Prices ... Oh, My Goodness!


IPI expert referenced: Merrill Matthews

It's an issue of bipartisan concern, but what can be done to fix prescription drug prices?

January 10, 2018

Where's the Proof Climate Change Causes the Polar Vortex?


Liberals, the media and even a fair number of scientists feel compelled to reassert that the excessive cold is “the result of global warming.”

January 9, 2018

One BIG Reason Why Prescription Drugs Cost So Much


Pfizer has ended its quest to find a cure for Alzheimer’s and Parkinson’s disease, but the research costs live on and must be absorbed in the price of other products.   

January 3, 2018

U.S. Trade Agreements: Reasons For Restraint


IPI expert referenced: Merrill Matthews

As Merrill Matthews of the Institute for Policy Innovation noted in a Jan. 2 Wall Street Journal op-ed column, NAFTA participants Canada, Mexico and the United States are codependent on energy and benefit from the trade agreement’s tariff terms.

January 3, 2018

How Trump's Second Year Can Top His First


President Trump made a lot of progress in 2017—a lot more than many expected. Now the question is whether his second year can top his first. 

January 2, 2018

Free Trade Has Been A Boon to Energy Independence


Energy independence for the U.S. alone is still years away. But thanks to free trade, energy independence for North America is within our grasp. A modernized Nafta can help make that goal a reality very soon.

December 17, 2017

How Average Americans Benefit From the GOP Tax Reform


Here’s one way millions of Americans will benefit from the Republican tax reform, even if they don’t benefit directly from lower tax rates: the booming stock market.

December 12, 2017

We May All Be Exempt from Obamacare's Mandate--Sooner or Later


Obamacare drafters created an escape hatch, which they never thought they'd see it being used: the law's definition of "affordable" coverage. It allows people to escape the mandate if insurance is too expensive—which it increasingly is.

December 5, 2017

Kids Get Health Coverage While Taxpayers Get the Shaft


The “crowd-out effect” of CHIP would be an important lesson to remember as Congress tackles welfare reform next year.

 

Total Records: 1077

 

 

  • TaxBytes-New

Copyright Institute for Policy Innovation 2018. All Rights Reserved Privacy Policy Contact IPI.

e-resources e-resources